| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8805357 | American Journal of Otolaryngology | 2017 | 5 Pages |
Abstract
Adjuvant therapy does not appear to provide a significant survival benefit in resected sinonasal melanomas regardless of margin status, except those with stage IVB disease. Practitioners should carefully consider the added benefit of adjuvant therapy in these patients.
Related Topics
Health Sciences
Medicine and Dentistry
Otorhinolaryngology and Facial Plastic Surgery
Authors
Gaurav S. Ajmani, Erik Liederbach, Alex Kyrillos, Chi-Hsiung Wang, Jayant M. Pinto, Mihir K. Bhayani,